Cygnus GlucoWatch G2
This article was originally published in The Gray Sheet
Executive Summary
PMA supplement approval for next-generation glucose monitor system is announced April 2. Enhancements over earlier model include a shorter waiting period between readings, an ability to display and store readings every ten minutes, and an audible alert providing "predictive" notification before a pre-set low glucose level is encountered. U.S. sales of the first-generation system, approved in March 2001, are expected to begin in the next few weeks. Introduction the G2 system will happen later this year...
You may also be interested in...
Cygnus GlucoWatch Biographer For Children To Launch In September
Cygnus plans to offer a pediatric version of its GlucoWatch Biographer for about $700 when shipments begin in late September
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.